Minerva Neurosciences (NERV) Earnings Date & Reports

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

NERV is expected to report earnings to rise 50.00% to -20 cents per share on November 11

Minerva Neurosciences NERV Stock Earnings Reports

Q3'26

Est.

$-0.21

Q2'26

Beat

by $0.05

Q1'26

Missed

by $0.04

Q4'25

Missed

by $0.53

Q3'25

Missed

by $0.01

The last earnings report on August 07 showed earnings per share of -14 cents, beating the estimate of -18 cents. With 53.84K shares outstanding, the current market capitalization sits at 231.10M.

View a ticker or compare two or three

NERV

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days